Flexus Biosciences

Developer of small-molecule cancer therapeutics designed to target regulatory T cells. The company is focused on the creation, development and commercialization of novel anti-cancer therapeutics, particularly immunotherapies targeting regulatory T cells enabling healthcare providers to treat cancer effectively.

Kleiner Perkins

🏥 Healthcare